Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 6,240 shares at $158.88 ($989K) on 2021-05-10, disclosed to the SEC on 2021-05-11.
Open-market sale of $989k MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.60 | 600 | $94K | 9.5% |
| 2 | $157.48 | 985 | $155K | 15.7% |
| 3 | $157.48 | 985 | $155K | 15.7% |
| 4 | $158.88 | 1,585 | $252K | 25.5% |
| 5 | $158.88 | 1,585 | $252K | 25.5% |
| 6 | $159.63 | 200 |
| $32K |
| 3.2% |
| 7 | $161.64 | 100 | $16K | 1.6% |
| 8 | $163.12 | 200 | $33K | 3.3% |
| Total | $158.42 avg | 6,240 | $989K | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |